NCT06285227View on ClinicalTrials.gov

Study of CM313 in Healthy Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

March 12, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Healthy
Interventions
BIOLOGICAL

CM313 injection

CM313

Trial Locations (1)

Unknown

RECRUITING

Huashan Hospital Fudan University, Shanghai

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT06285227 - Study of CM313 in Healthy Subjects | Biotech Hunter | Biotech Hunter